Investor mix
8 investors on record; lead investors include Regeneron Pharmaceuticals, Invest-NL.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Private equity | 2 | 25% |
| Other / undisclosed | 2 | 25% |
Developer of therapeutic vaccines for cancer and infectious diseases
8 investors on record; lead investors include Regeneron Pharmaceuticals, Invest-NL.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Private equity | 2 | 25% |
| Other / undisclosed | 2 | 25% |